Events › B2B Event
B2B Event
7th edition
The 7th Genome Editing Therapeutics Summit 2026 focuses on advancing genome editing therapies from scientific innovation to safe, scalable clinical applications. It covers in vivo and ex vivo delivery, regulatory compliance, and manufacturing challenges for drug development leaders.
Exhibitor mix: Sponsors and partners listed by category (e.g., event partners).
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Why people attend
To find partners for delivering gene therapies, discover novel safety screening tools, evaluate CMC strategies, and meet with C-suite and VP-level decision-makers in biopharma.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
More events in United States
Frequently asked questions